In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Codexis Inc (NASDAQ: CDXS) was $2.41 for the day, down -3.98% from the previous closing price of $2.51. In other words, the price has decreased by -$3.98 from its previous closing price. On the day, 1.45 million shares were traded. CDXS stock price reached its highest trading level at $2.52 during the session, while it also had its lowest trading level at $2.3946.
Ratios:
Our analysis of CDXS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.70 and its Current Ratio is at 5.82. In the meantime, Its Debt-to-Equity ratio is 1.24 whereas as Long-Term Debt/Eq ratio is at 1.19.
On May 30, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on May 30, 2024, with a $11 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 31 ’25 when Opaleye Management Inc. bought 84,220 shares for $2.68 per share. The transaction valued at 225,710 led to the insider holds 12,544,220 shares of the business.
Opaleye Management Inc. bought 780 shares of CDXS for $2,211 on Aug 04 ’25. The 10% Owner now owns 12,545,000 shares after completing the transaction at $2.83 per share. On Jul 29 ’25, another insider, Opaleye Management Inc., who serves as the 10% Owner of the company, bought 8,422 shares for $2.82 each. As a result, the insider paid 23,750 and bolstered with 12,458,422 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 217544688 and an Enterprise Value of 220194592. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.81 while its Price-to-Book (P/B) ratio in mrq is 3.91. Its current Enterprise Value per Revenue stands at 3.852 whereas that against EBITDA is -4.212.
Stock Price History:
The Beta on a monthly basis for CDXS is 2.54, which has changed by -0.14234877 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, CDXS has reached a high of $6.08, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is -14.16%, while the 200-Day Moving Average is calculated to be -27.56%.
Shares Statistics:
CDXS traded an average of 1.01M shares per day over the past three months and 1400420 shares per day over the past ten days. A total of 90.25M shares are outstanding, with a floating share count of 87.50M. Insiders hold about 3.07% of the company’s shares, while institutions hold 79.85% stake in the company. Shares short for CDXS as of 1755216000 were 5189591 with a Short Ratio of 5.16, compared to 1752537600 on 5699514. Therefore, it implies a Short% of Shares Outstanding of 5189591 and a Short% of Float of 5.84.
Earnings Estimates
The market rating for Codexis Inc (CDXS) is a result of the insights provided by 3.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.08 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.5 and -$0.68 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.62, with 2.0 analysts recommending between -$0.61 and -$0.63.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 7 analysts. It ranges from a high estimate of $20.2M to a low estimate of $16.27M. As of the current estimate, Codexis Inc’s year-ago sales were $12.83MFor the next quarter, 7 analysts are estimating revenue of $24.3M. There is a high estimate of $26.87M for the next quarter, whereas the lowest estimate is $22.21M.
A total of 7 analysts have provided revenue estimates for CDXS’s current fiscal year. The highest revenue estimate was $67.7M, while the lowest revenue estimate was $62.82M, resulting in an average revenue estimate of $65.66M. In the same quarter a year ago, actual revenue was $59.34MBased on 6 analysts’ estimates, the company’s revenue will be $79.88M in the next fiscal year. The high estimate is $87.6M and the low estimate is $75.5M.
